KEY FEATURES
KEY FEATURES
Why Anemocyte?
WHY ANEMOCYTE?
Anemocyte has several peculiar traits which distinguish it from other players in the market and can benefit the project and its successful execution overall.
Established experience in nucleic acids development and manufacturing
Anemocyte has gained relevant experience in the realm of plasmid manufacturing.
In this regard, the company can count on a long-term experience dealing with a wide range of Projects and Products.
Leveraging on such established know-how Anemocyte has expanded its competencies and capabilities to timely and effectively address mRNA development and manufacturing.
Private ownership
Anemocyte is a family-owned business, founded on a responsible entrepreneurial long-term vision and values such as stability, flexibility, strong know-how and customer focus;
Financial stability
Anemocyte is a debt-free company that can count on the full support of its Shareholder to deploy its long-term growth strategy;
Established pDNA and mRNA analytical experience and competencies in-house
Anemocyte can manage the vast majority of the required analyses in-house;
Dedicated and ambitious Innovation & Development multi-year plan
Anemocyte is working on innovative solutions to timely and effectively respond to continuously evolving clients and market’s needs.
Examples of areas of focus:
- innovative drug delivery systems,
- innovative formulation, improved design for nucleic acid,
- process optimization to limit impurities and increase the safety of the products.
